NanoVation Therapeutics UK

overview

NanoVation Therapeutics (NTx) is a delivery technology company focused on the development and optimisation of next-generation lipid nanoparticle (LNP) gene delivery technologies to enable and expande the scope of gene therapy. NTx is payload, target and disease agnostic and works through academic and commerical collaborative partnerships to design, optimize and assess pre-clinical performance of LNP-based gene therapies for specific applications. A key R&D focus of the company is to achieve efficient gene delivery to extrahepatic tissues.